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Cervical intraepithelial neoplasias (CIN) are Human papillomavirus/HPV-related 
lesions in which p16 is a key cell-cycle molecule induced by HPV integration in host 
cell DNA and directly correlated to the progression risk. In pregnancy, CIN lesions seem 
to have a favourable behavior and a high rate of regression, allowing a delayed treat-
ment of the patients after delivery. The mechanisms underlying this biologic behavior 
are not understood, but suggest the important role played by factors directly related to 
the pregnancy. We focused our attention on glycodelin, which is a molecule highly ex-
pressed in uterine tissues during pregnancy with immunosuppressive properties which 
might influence the progression of Human papillomavirus/HPV-related CIN lesions. 
Glycodelin has been previously found in 60% of CIN cases, but no data are available for 
pregnant patients. The aim of our study was to compare immunoreactivity for glycode-
lin and p16 in 27 cases of CIN, diagnosed in 12 pregnant and 15 nonpregnant patients. 
Cases were classified as CIN I (5 cases), CIN II (8 cases), and CIN III (14 cases): no dif-
ferences of histological grade were noted between pregnant and nonpregnant patients 
(P=0.10). Glycodelin expression appeared to be significantly lower in dysplastic lesions 
compared to normal squamous epithelium adjacent to CIN, but no differences of expres-
sion were noted among different histological grades and between the two groups of 
patients. p16 expression was highly correlated with CIN histological grade, but only in 
the nonpregnant group; in pregnant patients, instead, a loss of correlation between p16 
and histological grade was observed; moreover, only in this subgroup of patients, p16 
expression was inversely correlated with glycodelin. Our results suggest that in preg-
nancy, when CIN lesion has glycodelin preservation as in the normal epithelium, p16 
might be not overexpressed. A possible explanation for these observations might be that 
during pregnancy, preservation of glycodelin might be a epiphenomenon of unknown 
mechanisms protecting dysplastic epithelia from HPV integration in the host cell DNA, 
thus reducing p16 expression and preventing risk progression, independently from the 
histological grade of the lesion.
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